Our contributor is taking some major profits on his 2020 Top Pick—triple digits!
Sell: Inovio Pharmaceuticals, Inc. (INO)
From Cotton’s Technically Speaking
Inovio Pharmaceuticals is a late stage biotechnology that focuses on the discovery, development and commercialization of DNA-based immunotherapies and vaccines to prevent and treat cancers and infectious diseases.
The company became a “Hot Stock” after it entered the fray to develop a Covid-19 vaccine. The company also just recently received a $71 Million contract to scale up manufacture of its CFLLECTRA 3PSP Smart Device for administering its Covid -19 DNA Vaccine directly into the skin.
The stock was up 932% in 6 months as of yesterday’s close. We sold our position on 6/29/20 at $28.32, for a gain of 832%, because we wanted to be sure to book those huge profits. The stock could double from here, but we’re not sure. Some “old timers” would rather have sold half of the position, and let the rest ride. But we chose to sell.
Joseph Cotton, Cotton’s Technically Speaking, cottonstocks.net, 727-289-4436, June 30, 2020